공지사항

Acute Myeloid Leukemia

AML is a condition that causes abnormal white blood cells overtake healthy blood cells and hinder the bone marrow's function be normal. The disease can cause damage to other parts of your body, too.

Hematopoietic Stem Cell Transplant is a complex procedure available only in specialist centers. This procedure is correlated with social and economic factors like poverty, rurality and being an aboriginal or visible minority.

Signs and symptoms

Acute myeloid (AML) leukemia is a cancer that afflicts the bone marrow and blood which is the spongy part of bones where blood cells are formed. This condition develops when blood stem cells, Canadian national railway all which normally mature into mature red and white blood cells, platelets and platelets, become abnormal. They block healthy blood cells. The term "acute" is used because it can get worse very quickly.

AML may present with a variety of various symptoms and signs. The majority of these symptoms are caused by a shortage of normal blood cells. Leukemia cells overtake blood-making cells of the bone marrow. This means that there are not enough healthy circulating red blood cells. There isn't enough healthy white blood cells to fight off infections. There aren't enough healthy platelets to stop bleeding.

Other symptoms of AML include fever, fatigue bleeding, easy bruising and the enlargement of organs (spleen and liver). The reason for these symptoms is not always evident. These symptoms could be caused by leukemia, however, they could also be caused by radiation exposure or genetic disorders.

AML is the most prevalent form of acute leukemia that is found in adults. It can be affected by anyone, but is more prevalent in older people. People with certain genetic disorders such as Fanconi Anemia and Down Syndrome or hereditary tumor syndromes such as Li-Fraumeni syndrome are also more vulnerable.

Diagnosis

Normally, blood stem cells within the bone marrow grow into different kinds of mature blood cells as time passes. These include platelets that help blood clots, as well as red blood cells that carry oxygen. Acute myeloid leukemia is a cancer that affects the blood-forming cells of the bone marrow. This kind of leukemia happens when blood cells that are immature transform into abnormal leukemias which aren't functioning properly.

AML can trigger symptoms like fatigue, weakness, and bleeding or bruising. People with AML often have low numbers of white blood cells (leukopenia) or red blood cells (anemia).

AML is detected by laboratory tests which examine the bone-marrow and blood. These tests can reveal a large number of leukemia cells. The diagnosis is confirmed with tests for chromosomal alterations, such as FISH or molecular tests.

In general the classification of leukemias is based on the type of stem cell that becomes cancerous. There are two main types of leukemia: lymphoid and myeloid. Lymphocytic leukemias develop from lymph stem cells, which transform into the immune system's B and T cells. Myeloid leukemias originate from myeloid cells that create platelets and red blood cells. Acute myeloidleukemia can result from a variety of genetic mutations, such as the translocation t(8;21)(q22;q22).

Treatment

Adult acute myeloid leukemia occurs when the bone marrow makes too many abnormal blood cells. These cells can affect the red blood cells, platelets, and white blood cells. It may also cause bleeding or bruising that is easy to heal. Smoking or having had chemotherapy prior to it and exposure to radiation can increase the risk of AML.

AML is the most common type of cancer found in blood and bone marrow. It can be hard to treat, but new treatments are being tested in clinical trials.

The initial phase of treatment is known as induction therapy. This treatment puts the leukemia in Remission by killing the abnormal cells. Patients typically stay in the hospital during this period. Patients are given antibiotics and medications to increase the number of white blood cells. They might also need to receive blood product transfusions as well as medicines to can stop infections.

After the leukemia has been in the remission phase for some time, a further treatment (called Postremission Therapy) is administered to destroy any remaining leukemia cells that may grow and bring the cancer back into active status. Every patient will receive a different drug combination for this stage. The chemo drugs that are used depend on whether the AML has spread to the brain and spinal cord or not. Radiation therapy can also help. This could include external radiation to the region that is affected by cancer or total body irradiation, which sends radiation towards the entire body.

Prevention

Acute myeloid cancer is among Canada's most common cancers. AML incidence increases with age, and it is expected to rise in the canadian national railway acute myeloid leukemia canadian national railway pulmonary fibrosis canadian national railway chronic lymphocytic leukemia all (Od Thenz site) population due to the ageing of the population. A recent HMGA2 prognostic test has improved genetic risk stratification for AML and is a possible instrument to help guide treatment decisions. This paper presents a cost-effectiveness lifetime horizon model that evaluates the HMGA2 from both a health care system perspective as well as a social perspective in comparison to standard of care. The model incorporates physician and patient preferences and an analysis of sensitivity of cost-effectiveness results. The results support the use of the HMGA2 for Canadian national railway All AML in Canada.